Pigmented uveal tumours in a transgenic mouse model

British Journal of Ophthalmology

Volumn 82, Issue 8, 1998, Pages 953-960

  Kramer, Theresa R ^a   Powell, Marianne B ^b   Wilson, Matthew M ^c   Salvatore, Jennifer ^b   Grossniklaus, Hans E ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; UVEA MELANOMA; UVEA TUMOR;

EID: 0031684833     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.8.953     Document Type: Article

References (66)

1. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study, COMS Report 3. Control Clin Trials 1993;14:362-91.
2. Egan KM, Seddon JM, Glynn RJ, et al. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
3. Albert DM, Shadduck JA, Liu HS, et al. Animal models for the study of uveal melanoma. [Review] Int Ophthalmol Clin 1980;20:143-60.
4. Niederkorn JY. Suppressed cellular immunity in mice harboring intraocular melanomas. Invest Ophthalmol Vis Sci 1984;25:447-54.
5. Grossniklaus HE, Barron BC, Wilson MW. Murine model of anterior and posterior ocular melanoma. Curr Eye Res 1995;14:399-404.
6. Grossniklaus HE, Wilson MW, Barron BC, et al. Anterior vs posterior intraocular metastatic differences in a murine model. Arch Ophthalmol 1996;114:1116-20.
7. Anand R, Ma D, Alizadeh H, et al. Characterization of intraocular tumors arising in transgenic mice. Invest Ophthalmol Vis Sci 1994;35:3533-9.
8. Bradl M, Klein-Szanto A, Porter S, et al. Malignant melanoma in transgenic mice. Proc Natl Acad Sci USA 1991;88:164-8.
9. Klein-Szanto A, Bradl M, Porter S, et al. Melanosis and associated tumors in transgenic mice. Proc Natl Acad Sci USA 1991;88:169-73.
10. Powell MB, Hyman P, Bell OD, et al. Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 Ha-ras gene regulated by a mouse tyrosinase promoter. Mol Carcinog 1995;12:82-90.
11. Syed NA, Windle JJ, Darajatmoko SR, et al. Natural history of a transgenic model of intraocular melanoma. Invest Ophthalmol Vis Sci 1995;35(suppl):S1131.
12. Tanaka S, Yamamoto H, Takeuchi S, et al. Melanization in albino mice transformed by introducing cloned mouse tyrosinase gene. Development 1990;108:223-7.
13. Bailleul B, Lang J, Wilkie N, et al. A human T24 Ha-ras cassette suitable for expression studies in eukaryotic cells. Nucleic Acids Res 1988;16:359.
14. Albert DM, Shadduck JA, Liu HS, et al. Animal models for the study of uveal melanoma. [Review] Int Ophthalmol Clin 1980;20:143-60.
15. Albert DM, Wagoner MD, Moazed K, et al. Heterotransplantation of human choroidal melanoma into the athymic "nude" mouse. Invest Ophthalmol Vis Sci 1980;19:555-9.
16. Felberg NT, Michelson JB. Pigmented iris malignant melanoma in New Zealand white rabbits. (Abstract) Ophthalmic Res 1979;11:199.
17. Gallie BL, Albert DM, Wong JJ, et al. Heterotransplantation of retinoblastoma into the athymic "nude" mouse. (Abstract) Invest Ophthalmol Vis Sci 1977;16:256.
18. Krohn DL, Brandt R, Morris DA, et al. Subchoroidal transplantation of experimental malignant melanoma. (Abstract) Am J Ophthalmol 1970;70:7531.
19. Benson WR. Intraocular tumor after ethionine and N-2-fluorenyl-acetamide. (Abstract) Arch Pathol 1962;73:404.
20. Damjanov I, Sunderman FW, Mitchell JM, et al. Induction of testicular sarcomas in Fischer rats by intratesticular injection of nickel subsulfide. (Abstract) Cancer Res 1978;38:268.
21. Furst A, Haro RT, Schlauder M. Experimental chemotherapy of nickel-induced fibrosarcomas. (Abstract) Oncology 1972;26:422.
22. Gilman JPW. Metal carcinogenesis: a study on the carcinogenic activity of cobalt, copper, iron, and nickel compounds. (Abstract) Cancer Res 1962;22:158.
23. Herlyn M, Satyamoorthy K. Activated ras. Yet another player in melanoma? Am J Pathol 1996;149:739-44.
24. Zimmerman LE. Melanocytes, melanocytic nevi and melanocytomas. Invest Ophthalmol Vis Sci 1965;4:11-41.
25. Juarez CP, Tso MO. An ultrastrucrural study of melanocytomas (magnocellular nevi) of the optic disc and uvea. Am J Ophthalmol 1980;90:48-62.
26. Margo CE, Grossniklaus HE. In: Zorab R, ed. Ocular histopathology: a guide to differential diagnosis. Philadelphia: Saunders, 1991.
27. Spencer WH, ed. Ophthalmic pathology: an atlas and textbook. 4th ed. Philadelphia: Saunders, 1996.
28. Hogan MJ, Alvarado JA, Weddell JE. Histology of the human eye: an atlas and textbook. Philadelphia: Saunders, 1971.
29. Streeten BW. Development of the human retinal pigment epithelium and the posterior segment. Arch Ophthalmol 1968;81:383-384.
30. Beerman F, Schmid E, Schutz G. Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic mice. Proc Natl Acad Sci USA 1992;89:2809-13.
31. Rugh R. The mouse: its reproduction and development. Oxford: Oxford University Press, 1990.
32. Callendar GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931;36:131-42.
33. Gamel JW, McLean IW, Foster WD, et al. Uveal melanomas; correlation of cytologic features with prognosis. Cancer 1978;41:1897-901.
34. Gamel JW, McLean PW, Greenberg RA, et al. Computerized histologic assessment of malignant potential: a method for determining the prognosis of uveal melanomas. Hum Pathol 1982;13:893-7.
35. McClean IW, Zimmerman LE, Evans RM. Reappraisal of Callendar's spindle: a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol 1978;86:557-64.
36. Gause PR, Lluria-Prevatt M, Keith WN, et al. Chromosomal and genetic alterations of 7,12-dimethylbenz(a) anthracene-induced melanoma from TP-ras transgenic mice. Mol Carcinog 1997;20:78-87.
37. Barr CC, Zimmerman LE, Curtin VT, et al. Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. Arch Ophthalmol 1982;100:249-55.
38. Haas BD, Jakobiec FA, Iwamoto T, et al. Diffuse choroidal melanocytoma in a child: a lesion extending the spectrum of melanocytic hamartomas. Ophthalmology 1986;93:1632-8.
39. Gonder JR, Shields JA, Albert DM. Malignant melanoma of the choroid associated with oculodermal melanocytosis. Ophthalmology 1981;88:372-6.
40. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. III. The relationship of congenital ocular melanocytosis and neuronbromatosis to uveal melanomas. Arch Ophthalmol 1967;77:331-6.
41. Albert DM, Scheie HG. Nevus of Ota with malignant melanoma of the choroid: report of a case. Arch Ophthalmol 1963;69:774-7.
42. Coats G. Unilateral diffuse melanosis of the uvea, with small elevations on the surface of the iris. Trans Ophthalmol Soc UK 1912;32:165-71.
43. Font RL, Reynolds AM Jr, Zimmerman LE. Diffuse malignant melanoma of the iris in the nevus of Ota. Arch Ophthalmol 1967;77:513-18.
44. Frezzotti R, Guerra R, Dragoni GP, et al. Malignant melanoma of the choroid in a case of naevus of Ota. Br J Ophthalmol 1968;52:922-4.
45. Halasa A. Malignant melanoma in a case of bilateral nevus of Ota. Arch Ophthalmol 1970;84:176-8.
46. Makley TA Jr, King CM. Malignant melanoma in a case of bilateral nevus of Ota. Trans Am Acad Ophthalmol Otolaryngol 1967;71:638-41.
47. Reese AB. Melanosis oculi. A case with microscopic findings. Am J Ophthalmol 1925;8:865-70.
48. Roy PE, Schaeffer EM. Nevus of Ota and choroidal melanoma. Surv Ophthalmol 1967;12:130-4.
49. Sabates FN, Yamashita T. Congenital melanosis oculi complicated by two independent malignant melanomas of the choroid. Arch Ophthalmol 1967;77:801-3.
50. Seelenfreund MH, Freilich DB. Ocular melanocytosis and malignant melanoma. NY State J Med 1979;79:916-17.
51. Yamamoto T. Malignant melanoma of the choroid in the nevus of Ota. Ophthalmologica 1969;159:1-10.
52. Naumann G, Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol 1966;76:784-96.
53. Nuss DD, Aeling JL, Clemons DE, et al. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol 978;114:743-6.
54. Brownstein MH, Mehnegan AH, Bikowski JB. Trichilemmomas in Cowden's disease. JAMA 1977;238:26.
55. Curth HO, Hilberg AW, Machacek GF. The site and histology of the cancer associated with malignant acanthosis nigricans. Cancer 1962;15:364-82.
56. Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine 1968;47:33-51.
57. Ryll DL, Campbell RJ, Robertson N, et al. Pseudometastatic lesions of the choroid. Ocular Pathol Clinicians 1980;87: 1181-6.
58. Blodi FC, Reuling H, Sornson ET. Pseudomelanocytoma at the optic nervehead. Arch Ophthalmol 1965;73:353-5.
59. McLean EB. Hamartoma of the retinal pigment epithelium. Am J Ophthalmol 1976;82:227-31.
60. Font RL, Moura RA, Shetlar DJ, et al. Combined hamartoma of sensory retina and retinal pigment epithelium. Retina 1989;9:302-11.
61. Schachat AP, Shields JA, Fine SL, et al and The Macula Society Research Committee. Combined hamartomas of the retinal pigment epithelium. Ophthalmology 1984;91: 1609-15.
62. Kurz GH, Zimmerman LE. Vagaries of the retinal pigment epithelium. Int Ophthalmol Clin 1962;2:441-64.
63. Garner A. Tumours of the retinal pigment epithelium. Br J Ophthalmol 1970;54:715-23.
64. Tso MOM, Albert DM. Pathological condition of the retinal pigment epithelium. Arch Ophthalmol 1972;88:27-36.
65. Font RL, Spaulding AG, Zimmerman LE. Diffuse malignant melanoma of the uveal tract. A clinicopathologic report of 54 cases. Trans Ant Acad Ophthalmol Otolaryngol 1968;72:877-94.
66. Schena M, Shalon D, Heller R, et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996;93:10614-19.